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Prevalence and risk factors for cervical neoplasia:
a cervical cancer screening program in Beijing
Lixin Tao1,2†, Lili Han3†, Xia Li1,2, Qi Gao1,2, Lei Pan1,2, Lijuan Wu1,2, Yanxia Luo1,2, Wei Wang1,2,4, Zihe Zheng1,2
and Xiuhua Guo1,2*
Abstract
Background: Cervical cancer is the second most common cancer and cause of cancer-related death for women
worldwide. The aims of this study were to investigate the prevalence of cervical neoplasia and examine factors
associated with high-grade cervical squamous intraepithelial lesions (HSIL) among women taking part in a cervical
cancer screening program in Beijing.
Methods: Women aged 25–65 years were screened using the ThinPrep cytologic test and gynecologic examination.
Univariate and multivariate logistic regressions were conducted to investigate factors associated with HSIL.
Results: Among 728,704 women screened, the prevalence of cervical intraepithelial neoplasia (CIN) I, II, III was 50.2,
34.0, and 36.4 per 100,000, respectively. Prevalence of cervical cancer was 12.2 per 100,000. Risk factors for HSIL
included being in age group of 46–55 years (adjusted odds ratio [aOR] = 1.15, 95% CI: 1.07–1.44, compared with the
25–35 age group), bleeding after intercourse (aOR = 2.08, 95% CI: 1.40–3.10), and presence of trichomonas vaginalis
infection (aOR = 2.62, 95% CI: 1.35–5.07), cervical inflammation (aOR = 4.22, 95% CI: 3.39–5.26), and genital warts
(aOR = 3.89, 95% CI: 2.54–7.70). High education level (college and above compared with junior middle school or lower)
was found to be protective (aOR = 0.79, 95% CI: 0.37–0.90).
Conclusions: The prevalence of cervical neoplasia is relatively high in Beijing. Women aged 46–55 years, those with a
lower education level, those reporting bleeding after intercourse, and those affected by Trichomonas vaginalis infection,
cervical inflammation and genital warts are at higher risk for HSIL. Particular efforts should be made to ensure these
women are included in cervical cancer screening programs.
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Background
Cervical cancer is the second most common cancer and
cause of cancer-related death in women worldwide [1,2].
Cervical intraepithelial neoplasia (CIN) refers to changes
in squamous cells of the cervix, where more extensive
changes (CIN grades II and III) are known as high-grade
squamous intraepithelial lesions (HSIL). At least 25% of
women with HSIL will progress to carcinoma in situ or
invasive cancer if lesions are left untreated [3]. The identi-
fication of risk factors for HSIL is of pivotal importance.
Evidence suggests that human papillomavirus (HPV) in-
fection and health-related lifestyles influence the progression
of CIN. HPV plays a crucial role in the development of
cervical cancer and the precursor lesions. HPV is es-
sential to the transformation of cervical epithelial cells,
particularly subtypes 16 and 18 [4-6]. However, only a
minority of women infected with HPV progress to CIN
or HSIL. Therefore, cofactors that aid viral persistence
and disease progression must exist.
A positive association between smoking and cervical
cancer has consistently been observed, across different
geographic regions [7-9]. Dose–response associations
with smoking intensity and duration were detected in a
previous study [10]. However, adenocarcinoma of the
cervix, which usually accounts for less than 10% of all
cervical cancers, has no significant association with
smoking [11]. Increased risk of invasive cervical cancer
with exposure to passive smoking during adulthood has
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been demonstrated [12,13]. Indoor exposure to cooking
oil fumes is associated with CIN [3], while cooking in
kitchens equipped with fume extractors and keeping
extractors on while cooking can protect women from
this risk [14].
In recent years, strong evidence from many epidemio-
logic and experimental studies has emerged, demonstrat-
ing that inflammation also plays an important role in the
development of CIN and cervical cancer [15,16]. An asso-
ciation between the use of anti-inflammatory drugs and
reduced risk of cancer, as well as a decrease in precancer-
ous lesions, was shown in epidemiologic studies [16,17].
Factors relating to sexual behavior have also been
linked to cervical cancer and its precursors. Studies have
demonstrated that bacterial vaginosis and Trichomonas
vaginalis infection are significantly associated with persist-
ent HPV infection and the development of cervical cancer
[18-20]. Many studies have also suggested that women
with multiple sexual partners are at high risk for HPV
acquisition and cervical cancer [21,22]. Oral contraceptive
use is associated with the development of cervical cancer
[23-25]. A systematic review of hormonal contraceptive
use reported that the risk of in situ cervical cancer in-
creased even for women with less than 5 years’ hormonal
contraceptive use, but the risk of invasive cervical cancer
increased only after 5 years’ use. The risk for both condi-
tions declined with time since last use of hormonal
contraceptives, and there was no elevated risk for invasive
cervical cancer 10 years since the end of exposure [26].
The cervical cancer screening program was free for 25
to 65-year-old women permanently residing in Beijing in
2009. To the best of our knowledge, there has been no
similar, large-scale cervical cancer screening program
conducted in Beijing prior to this. The aims of the
present study were to estimate prevalence of cervical
neoplasia and explore potential risk factors for HSIL
among women living in Beijing.
Methods
Subjects
This study was conducted in 2009 as part of a national
program offering free cervical and breast cancer screening
for 25 to 65-year-old women permanently residing in
Beijing. All women aged 25–65 years who were willing to
participate in the screening program were included, with
the exception of those with a history of uterine sarcoma,
fallopian tube tumors, uterine fibroids, benign ovarian tu-
mors, ovarian cancer, vulvar carcinoma, vulvar malignant
melanoma, organ transplant or cancer treatment. Women
were informed of the purpose of the screening program
and gave their signed, informed consent prior to enrol-
ment. The study was approved by the Ethics Committee
of Beijing Obstetrics and Gynecology Hospital, Capital
Medical University.
Data collection
Data were collected by cervical cancer screening case
record cards. The cards recorded socio-demographic
information, reproductive history and sexual behavior,
medical history, gynecologic examination history, and
TCT and histologic test results.
A technical manual was designed to standardize the
screening process, and medical staff were trained prior
to commencement of the program. All gynecologic ex-
aminations were supervised and gynecologists conducted
each examination blinded to the results of the TCT test.
If TCT results were abnormal, subjects were referred for
histologic testing to determine CIN grade and to receive
relevant treatment. Approximately 10% of gynecologic
examinations were double-checked by experts and the
coincident diagnosis rate was 95%. Additionally, screening
experts checked 20% of the positive results and 10% of the
negative results. Approximately 5% of all record cards
were randomly checked and the proportion with errors or
omissions was less than 5%.
Socio-demographic information recorded for each
woman included age, education level, occupation, and
address. Information was also collected on reproductive
history and sexual characteristics, including length of
menstrual cycle, duration of menstrual period, gravidity,
parity, number of abortions, contraceptives used, reported
bleeding after intercourse, and detection of Trichomonas
vaginalis infection, yeast infection, bacterial vaginosis,
cervical inflammation, and genital warts. Medical history
included any history of uterine sarcoma, fallopian tube
tumors, uterine fibroids, ovary benign tumors, ovarian
cancer, vulvar carcinoma, vulvar malignant melanoma,
organ transplants, or cancer treatment.
Outcome variables
The primary study outcome was CIN grade, categorized
as: normal, CIN I, CIN II, CIN III, and cervical cancer.
HSIL was defined as CIN grades II and III.
Statistical analysis
Distributions of participants’ characteristics were examined
by rank-sum test, χ2, or Fisher’s exact test, as appropriate.
Participants with CIN II and CIN III grades were
combined as a HSIL group for subsequent univariate and
multivariate logistic regression analysis to assess the associ-
ation between HSIL and each potential risk factor. Data
were analyzed using SAS (version 9.2; SAS Institute,
Chicago, IL, USA) and ArcGIS (ArcGIS 10; ESRI Inc.,
Redlands, CA, USA).
Results
A total of 728,704 women from the 18 districts of Beijing
participated in the screening program, representing 9.4%
of the 25 to 65-year-old female population in Beijing in
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Table 1 The prevalence of CIN and cervical cancer
Districts Total CIN I
[n (/100,000)]
CIN II
[n (/100,000)]
CIN III
[n (/100,000)]
HSIL(CIN II/III)
[n (/100,000)]
Cervical cancer
[n (/100,000)]
Dongcheng 13194 6 (45.5) 3 (22.7) 4 (30.3) 7 (53.1) 1 (7.6)
Xicheng 27649 23 (83.2) 25 (90.4) 30 (108.5) 55 (198.9) 7 (25.3)
Chongwen 8382 3 (35.8) 3 (35.8) 5 (59.7) 8 (95.4) 0 (0.0)
Xuanwu 18787 1 (5.3) 3 (16.0) 11 (58.6) 14 (74.5) 1 (5.3)
Chaoyang 121141 128 (105.7) 71 (58.6) 69 (57.0) 140 (115.6) 25 (20.6)
Haidian 83442 27 (32.4) 27 (32.4) 21 (25.2) 48 (57.5) 4 (4.8)
Fengtai 63816 8 (12.5) 7 (11.0) 5 (7.8) 12 (18.8) 9 (14.1)
Shijingshan 25987 19 (73.1) 9 (34.6) 19 (73.1) 28 (107.8) 5 (19.2)
Mentougou 13395 8 (59.7) 3 (22.4) 20 (149.3) 23 (171.7) 1 (7.5)
Fangshan 72004 22 (30.6) 8 (11.1) 4 (5.6) 12 (16.7) 1 (1.4)
Daxing 53898 5 (9.3) 5 (9.3) 5 (9.3) 10 (18.6) 13 (24.1)
Tongzhou 26183 0 (0.0) 0 (0.0) 2 (7.6) 2 (7.6) 2 (7.6)
Shunyi 72194 32 (44.3) 22 (30.5) 19 (26.3) 41 (56.8) 6 (8.3)
Pinggu 30937 8 (25.9) 6 (19.4) 7 (22.6) 13 (42.0) 1 (3.2)
Huairou 46360 43 (92.8) 32 (69.0) 15 (32.4) 47 (101.4) 8 (17.3)
Miyun 22953 7 (30.5) 2 (8.7) 5 (21.8) 7 (30.5) 2 (8.7)
Changping 11570 3 (25.9) 2 (17.3) 1 (8.6) 3 (25.9) 1 (8.6)
Yanqing 16812 23 (136.8) 20 (119.0) 23 (136.8) 43 (255.8) 2 (11.9)
Total 728704 366 (50.2) 248 (34.0) 265 (36.4) 513 (70.4) 89 (12.2)
Abbreviations: CIN cervical intraepithelial neoplasia, HSIL high-grade squamous intraepithelial lesions.
Figure 1 The prevalence of a) HSIL and b) cervical cancer in 18 districts of Beijing. Abbreviation: HSIL = high-grade squamous intraepithelial lesion.
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Table 2 Basic characteristics of subjects
Variables Normal HSIL /100,000 P
Age group 26.93 <0.0001
25-35 76694 56 73.0
36-45 201001 151 75.1
46-55 283055 247 87.2
56-65 141418 59 41.7
Education level 7.89 0.0193
Junior middle school or lower 468032 365 77.9
High school or technical secondary school 156502 110 70.2
College and above 77634 38 48.9
Work or not 0.77 0.3807
Yes 487062 365 74.9
No 215106 148 68.8
Bleeding after intercourse 12.47 0.0004
No 682097 485 71.1
Yes 20071 28 139.3
Contraceptive used 195.00 <0.0001
Condom 340067 186 54.7
Contraceptive pills 11551 34 293.5
Intrauterine device use 196821 196 99.5
Security period 981 3 304.9
Coitus interruptus 7955 25 313.3
No contraceptive measures 144793 69 47.6
Trichomonas vaginalis − 0.0140
No 697064 504 72.3
Yes 5104 9 176.0
Yeast infection − 0.7595
No 698372 510 73.0
Yes 3796 3 79.0
Bacterial vaginosis − 0.5268
No 698835 510 72.9
Yes 3333 3 90.0
Cervical inflammation 191.77 <0.0001
No 658979 406 61.6
Yes 43189 107 247.1
Genital warts − 0.0013
No 699972 506 72.2
Yes 2196 7 317.8
Menstrual cycle 29 (28–30)a 29 (28–30)a . 0.67b 0.4140 b
Menstrual period 5 (4–6)a 5 (4–7)a . 2.97b 0.0851b
Gravity 2 (1–3)a 2 (2–3)a . 0.16b 0.6902b
Parity 1 (1–2)a 1 (1–1)a . 18.55b <0.0001b
Number of abortion 1 (1–2)a 1 (0–2)a . 2.77b 0.0963b
Total 702168 513
Abbreviations: HSIL high-grade squamous intraepithelial lesions. Trichomonas vaginalis is defined as vaginalis infected by trichomonas. Yeast infection is defined as
vaginosis infected by yeast. Bacterial vaginosis is defined as vaginosis infected by bacterial. Cervical inflammation is defined as moderate or serious inflammation.
a: Median (P25-P75).
b: Rank sum test.
−: Fisher’s exact test.
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Table 3 Risk factors for HSIL assessed by univariate logistic regression
Variables OR 95% CI for OR P
Lower Upper
Age group
25-35 Ref Ref Ref Ref
36-45 1.37 0.82 1.84 0.6521
46-55 1.15 1.01 3.98 0.0302
56-65 0.57 0.40 1.12 0.3601
Education level
Junior middle school or lower Ref Ref Ref Ref
High school or technical secondary school 1.68 0.98 2.04 0.3112
College and above 0.54 0.10 0.87 0.0261
Work or not
Yes Ref Ref Ref Ref
no 1.03 0.85 1.25 0.7356
Contraceptive used
Condom Ref Ref Ref Ref
Contraceptive pills 1.15 0.64 2.06 0.9484
Intrauterine device use 1.29 0.94 1.59 0.9442
Hypoderm contraceptive implants 1.13 0.88 2.14 0.9559
Security period 0.59 0.19 1.85 0.9720
Coitus interruptus 1.42 0.83 1.97 0.9406
No contraceptive measures 0.90 0.68 1.20 0.9568
Bleeding after intercourse
No Ref Ref Ref Ref
Yes 2.60 1.75 3.86 <0.0001
Trichomonas vaginalis
No Ref Ref Ref Ref
Yes 2.55 1.32 4.93 0.0055
Yeast infection
No Ref Ref Ref Ref
Yes 1.14 0.37 3.54 0.8248
Bacterial vaginosis
No Ref Ref Ref Ref
Yes 1.31 0.42 4.08 0.6389
Cervical inflammation
No Ref Ref Ref Ref
Yes 4.27 3.45 5.28 <0.0001
Genital warts
No Ref Ref Ref Ref
Yes 4.41 2.82 6.19 <0.0001
Menstrual cycle 1.00 0.99 1.01 0.9911
Menstrual period 1.02 0.97 1.08 0.4526
Gravity 0.99 0.92 1.06 0.7287
Parity 0.74 0.65 0.86 <0.0001
Number of abortions 0.98 0.63 1.53 0.9225
Abbreviations: HSIL high-grade squamous intraepithelial lesions, OR odds ratio, CI confidence interval.
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2009. Of these participants, 366 women (50.2 per 100,000)
were diagnosed as CIN I, 248 (34.0 per 100,000) as CIN II,
265 (36.4 per 100,000) as CIN III and 89 (12.2 per
100,000) as having cervical cancer. Prevalence of HSIL
(CIN grades II and III) was 70.40 per 100,000 women. The
prevalence of HSIL and cervical cancer by Beijing district
are shown in Table 1 and Figure 1. Yanqing district had
the highest prevalence of CIN I, CIN II, and HSIL, at
136.8, 119.0, and 255.8 per 100,000, respectively. The
highest prevalence of CIN III was in Mentougou district
(149.3 per 100,000) and the highest prevalence of cervical
cancer was in Xicheng district (25.3 per 100,000).There
were significant differences between women with HSIL
(n = 513) and those with normal histology (n = 702,168) in
terms of age group, education level, parity, bleeding after
intercourse, contraceptive used, presence of Trichomonas
vaginalis infection, cervical inflammation, and genital
warts. However, there was no significant difference in
terms of work or not, menstrual cycle, menstrual period,
gravidity, number of abortions, and presence of yeast
infection and bacterial vaginosis (Table 2). Risk factors
significantly associated with presence of HSIL in univari-
ate logistic regression were being in age band of 46–55
years (compared with the reference group 25–35 years),
higher education level, parity, bleeding after intercourse,
and presence of Trichomonas vaginalis, cervical inflam-
mation and genital warts (Table 3). Risk factors that
remained significant in multivariate logistic regression
were being in the age band of 46–55 years (adjusted odds
ratio [aOR] = 1.15, 95% CI: 1.07–1.44, compared with the
age band of 25–35 years), bleeding after intercourse (aOR =
2.08, 95% CI: 1.40–3.10), and presence of Trichomonas
vaginalis infection (aOR = 2.62, 95% CI: 1.35–5.07),
cervical inflammation (aOR = 4.22, 95% CI: 3.39–5.26)
and genital warts (aOR = 3.89, 95% CI: 2.54–7.70). Higher
education level was found to be protective against HSIL
(aOR = 0.79, 95% CI: 0.37–0.90, college and above com-
pared with junior middle school or lower education level)
(Table 4, Figure 2).
Discussion
This study represents the first large-scale cervical cancer
screening program in Beijing. Women in 18 districts
aged 25–65 years and with a registered, permanent
Beijing address were eligible to participate. However,
only 9.4% of eligible women were evaluated. The preva-
lence of CIN I, II, III, and cervical cancer was 50.2, 34.0,
36.4, and 12.2 per 100,000, respectively. Identified risk
Table 4 Risk factors for HSIL assessed by multivariate logistic regression
Variables OR 95% CI for OR P
Lower Upper
Age group
25-35 Ref Ref Ref Ref
36-45 1.46 0.88 1.98 0.2143
46-55 1.15 1.07 1.44 0.0254
56-65 0.78 0.52 1.16 0.4399
Education level
Junior middle school or lower Ref Ref Ref Ref
High school or technical secondary school 1.59 0.90 1.96 0.2416
College and above 0.79 0.37 0.90 0.0337
Bleeding after intercourse
No Ref Ref Ref Ref
Yes 2.08 1.40 3.10 0.0003
Trichomonas vaginalis
No Ref Ref Ref Ref
Yes 2.62 1.35 5.07 0.0043
Cervical inflammation
No Ref Ref Ref Ref
Yes 4.22 3.39 5.26 <0.0001
Genital warts
No Ref Ref Ref Ref
Yes 3.89 2.54 7.70 <0.0001
Abbreviations: HSIL high-grade squamous intraepithelial lesions, OR odds ratio, CI confidence interval.
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factors for HSIL in this population were being in the age
group of 46–55 years, bleeding after intercourse, presence
of Trichomonas vaginalis infection, cervical inflammation,
and genital warts, while higher education was found to be
protective.
Prevalence of precancerous cervical lesions (CIN grades
I–III) in this study population (0.12%) was lower than that
reported in 2009 (0.20%) [27]. Prevalence of cervical
cancer was 12.2 per 100,000, which is comparable to rates
reported elsewhere: 16.2 per 100,000 and 10.3 per 100,000
reported from more developed countries, and 19.1 per
100,000 reported from less developed countries [28].
While the study population in this study is predominantly
urban, there appears to be little difference in rates of
cervical cancer between urban and rural regions in China.
According to China Cancer Registration Annual Report
2004, in which 43 cancer registries were included, the
incidence of cervical cancer was 5.3 per 100,000 in
urban and 4.9 per 100,000 in rural areas [29].
Supporting results from previous studies, being aged
46–55 years and having a lower educational attainment
level were identified as significant risk factors for HSIL
in our study. A community-based screening program in
Hong Kong similarly found that women aged 40–49
years and women having received primary school
education only were at increased risk of cervical abno
rmalities [30]. Other studies have also identified older
age, high gravidity, and low educational status as sig-
nificant risk factors for development of cervical cancer
[31-34].
Our results show that women who reported bleeding
after intercourse had a higher risk of developing cer-
vical epithelial abnormality. This association has been
identified previously [35] and is not surprising, as blee
ding after intercourse may indicate vaginal infections,
cervical dysplasia, or uterine fibroids, all of which may
lead to cervical abnormalities.
There was a significant association between an abnormal
TCT test and having a history of gynecologic infections.
Trichomonas vaginalis infection was associated with a high
relative risk of HSIL. This supports previous findings: a
meta-analysis of 24 studies examining the association
between Trichomonas vaginalis infection and cervical
neoplasia (including both CIN and cervical cancer) found a
significant positive association [36]. There is some epide-
miologic evidence to suggest that genital tract disease such
as cervical inflammation might be linked to cervical cancer
or high-grade lesions [37,38], and a significant association
between cervical inflammation and HISL was identified in
this study. Trichomonas vaginalis may act as a cofactor
facilitating the development of cervical HPV infection to
high-grade lesion and cervical cancer [39,40]. Multiple
studies have demonstrated an association between previous
and current Trichomonas vaginalis infection and cervical
dysplasia and human papillomavirus [41-43]. A history of
genital warts has been reported as a good predictor of risk
for carcinoma in situ [44] and the similar association was
detected in the present study. The association between
genital warts and HISL is likely due to concurrent infection
with different HPV subtypes [45,46]. It is also probably
related to multiple sex partners [47].
There are some limitations to this study. First, the
authors did not receive information on many other
lifestyle factors that may potentially be associated with
development of cervical abnormalities. Information on
smoking, alcohol consumption and other lifestyle factors
is required to explore their association with HSIL. Sec-
ond, because of budget limitations, detection of HPV
infection was not included in this study, which is crucial
in the development of CIN and cervical cancer. Despite
this, the current study, benefitting from a large sample
size, provides valuable information for the assessment of
CIN and cervical cancer.
Conclusions
The prevalence of cervical neoplasia was relatively high.
Women in the age group of 46–55 years, those with
lower educational attainment, those reporting bleeding
after intercourse, and those suffering from Trichomonas
vaginalis infection, cervical inflammation and genital
warts are at high risk for HSIL. Particular efforts should
be made to ensure these women are included in cervical
cancer screening programs.
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